Does OMALIZUMAB Cause Pulmonary embolism? 308 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 308 reports of Pulmonary embolism have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.5% of all adverse event reports for OMALIZUMAB.
308
Reports of Pulmonary embolism with OMALIZUMAB
0.5%
of all OMALIZUMAB reports
24
Deaths
194
Hospitalizations
How Dangerous Is Pulmonary embolism From OMALIZUMAB?
Of the 308 reports, 24 (7.8%) resulted in death, 194 (63.0%) required hospitalization, and 46 (14.9%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for OMALIZUMAB.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which OMALIZUMAB Alternatives Have Lower Pulmonary embolism Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS